Ergomed (ERGO.L) Financials

£85.1 M

Mkt cap, 31-Oct-2017

£39.2 M

Revenue FY, 2016
Revenue growth (FY, 2015 - FY, 2016), %30%
Gross profit (FY, 2016)12 M
Gross profit margin (FY, 2016), %30.6%
Net income (FY, 2016)479 K
EBITDA (FY, 2016)854 K
EBIT (FY, 2016)598 K
Cash, 31-Dec-20164.4 M
EV80.7 M

Revenue/Financials

Income Statement

Annual

GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

7 m8.1 m9.6 m9.9 m12.1 m14.6 m15.1 m21.2 m30.2 m39.2 m

Revenue growth, %

40%43%30%

Cost of goods sold

5.7 m6 m6.4 m6.9 m8.1 m10.7 m10.1 m15.4 m21.8 m27.2 m

Gross profit

1.3 m2.1 m3.2 m3 m4 m3.9 m5 m5.8 m8.4 m12 m

Gross profit Margin, %

19%26%33%30%33%27%33%27%28%31%

Operating expense total

850.4 k2.1 m2.8 m2.7 m3.3 m3.5 m3.2 m5 m6.3 m11.4 m

EBITDA

509.7 k169.3 k462.4 k370.8 k670.5 k522 k1.8 m852 k2.2 m854 k

EBITDA margin, %

7%2%5%4%6%4%12%4%7%2%

EBIT

494.9 k20.3 k357.7 k306.4 k619.7 k465 k1.8 m779 k2.1 m598 k

EBIT margin, %

7%0%4%3%5%3%12%4%7%2%

Pre tax profit

498.4 k(12.4 k)312.5 k308.9 k633.2 k474 k1.8 m777 k2.1 m326 k

Income tax expense

(154.6 k)(27.3 k)(188 k)(98.9 k)(98.4 k)(83 k)(232 k)(199 k)(520 k)153 k

Net Income

343.8 k(39.7 k)124.5 k209.9 k534.7 k391 k1.5 m578 k1.6 m479 k

Balance Sheet

Annual

GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

452.5 k692.3 k467.9 k1 m642.2 k445 k2 m4.6 m4 m4.4 m

Accounts Receivable

1.8 m860.5 k2.1 m1.3 m3.1 m2.3 m2.3 m4.7 m6.4 m9.5 m

Current Assets

3.1 m1.9 m3.1 m2.9 m4.4 m4 m5.2 m10.9 m13.5 m19.8 m

PP&E

17 k476.1 k158.8 k175.7 k154.5 k164 k148 k185 k335 k717 k

Goodwill

1.3 m10.2 m10.3 m32.1 m

Total Assets

3.3 m2.4 m3.4 m3.1 m4.5 m4.2 m6.7 m21.7 m24.7 m54.4 m

Accounts Payable

423.3 k653.4 k998.3 k834.8 k1.4 m2.4 m2.5 m2.7 m2.4 m3 m

Current Liabilities

2.5 m2.4 m3.1 m2.9 m3.8 m3.8 m4.8 m5.8 m7.2 m8.6 m

Non-Current Liabilities

4.9 k18.9 k17.8 k9.4 k4.6 k31 k8 k581 k523 k11.2 m

Total Debt

294.4 k46.3 k67 k22 k7 k5 k3 k

Total Liabilities

2.5 m2.4 m3.1 m2.9 m3.8 m3.9 m4.8 m6.3 m7.8 m19.8 m

Additional Paid-in Capital

200 k200 k200 k200 k200 k200 k200 k288 k288 k406 k

Retained Earnings

143.8 k(119.7 k)124.5 k29.9 k534.7 k(409 k)1.5 m578 k1.6 m479 k

Total Equity

750.7 k2.1 k258.6 k271 k746.5 k353 k1.9 m15.3 m16.9 m34.6 m

Debt to Equity Ratio

137.3 x0.2 x0.2 x0 x0 x0 x0 x

Debt to Assets Ratio

0.1 x0 x0 x0 x0 x0 x0 x

Financial Leverage

4.4 x1.1 k x13 x11.6 x6.1 x12 x3.5 x1.4 x1.5 x1.6 x

Cash Flow

Annual

GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

343.8 k(39.7 k)124.5 k209.9 k534.7 k391 k1.5 m578 k1.6 m479 k

Cash From Operating Activities

191.7 k334.4 k(339.2 k)969 k(361.9 k)581 k1.4 m537 k264 k(2.4 m)

Dividends Paid

200 k180 k800 k

Cash From Financing Activities

(36.1 k)(99.4 k)(351.7 k)(15.9 k)(710 k)(68 k)9.1 m(1 k)8.7 m

Net Change in Cash

(92.8 k)161.8 k(224.4 k)572.3 k(398 k)(197 k)1.5 m2.6 m(602 k)450 k

Income Taxes Paid

(232 k)(199 k)(520 k)153 k

Ratios

GBPY, 2016

EV/EBITDA

94.5 x

EV/EBIT

134.9 x

EV/CFO

-34 x

Financial Leverage

1.6 x
Report incorrect company information

Operating Metrics

Ergomed's Customers was reported to be 100 in FY, 2015.
FY, 2015

Countries

54

Customers

100

Patients Studied

30 k
Report incorrect company information